[1] Shih, J. L. A., & Brugger, R. M. (1992). Gadolinium as a neutron capture therapy agent. Medical physics, 19(3), 733-744.
[2] Miller Jr, G. A., Hertel, N. E., Wehring, B. W., & Horton, J. L. (1993). Gadolinium neutron capture therapy. Nuclear technology,103(3), 320-331.
[3] Goorley, T., & Nikjoo, H. (2000). Electron and photon spectra for three gadolinium-based cancer therapy approaches. Radiation research, 154(5), 556-563.
[4] Stepanek, J. (2003). Emission spectra of Gadolinium‐158.Medical physics, 30(1), 41-43.
[5] Martin, R. F., D'Cunha, G., Pardee, M., & Allen, B. J. (1988). Induction of double-strand breaks following neutron capture by DNA-bound 157Gd. International Journal of Radiation Biology,54(2), 205-208.
[6] Kassis, A. I., Fayad, F., Kinsey, B. M., Sastry, K. S. R., Taube, R. A., & Adelstein, S. J. (1987). Radiotoxicity of 125I in mammalian cells. Radiation research, 111(2), 305-318.
[7] akrigiorgos, G. M., Kassis, A. I., Baranowska-Kortylewicz, J., McElvany, K. D., Welch, M. J., Sastry, K. S. R., & Adelstein, S. J. (1989). Radiotoxicity of in V79 Cells: A Comparison with.Radiation research, 118(3), 532-544.
[8] Narra, V. R., Howell, R. W., Harapanhalli, R. S., Sastry, K. S., & Rao, D. V. (1992). Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design. Journal of Nuclear Medicine,33(12), 2196-2201..
[9] Rao, D., Howell, R., Narra, V., Govelitz, G., & Sastry, K. R. (1989). In-vivo radiotoxicity of DNA-incorporated 125I compared with that of densely ionising alpha-particles. The lancet,334(8664), 650-653.
[10] Humm, J. L., Howell, R. W., & Rao, D. V. (1994). Dosimetry of Auger‐electron‐emitting radionuclides: Report No. 3 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics, 21(12), 1901-1915.
[11] Valentin, J. (2003). Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR): ICRP Publication 92. Annals of the ICRP, 33(4), 1-121.
[12] K. Weyrather, S. Ritter, M. Scholz, G. Kraft, W. (1999). RBE for carbon track-segment irradiation in cell lines of differing repair capacity. International journal of radiation biology, 75(11), 1357-1364.
[13] Goodhead, D. T., & Nikjoo, H. (1989). Track structure analysis of ultrasoft X-rays compared to high-and low-LET radiations.International Journal of Radiation Biology, 55(4), 513-529.
[14] Lindborg, L., Hultqvist, M., Tedgren, Å. C., & Nikjoo, H. (2013). Lineal energy and radiation quality in radiation therapy: model calculations and comparison with experiment. Physics in Medicine & Biology, 58(10), 3089.
[15] Lindborg, L., & Nikjoo, H. (2011). Microdosimetry and radiation quality determinations in radiation protection and radiation therapy. Radiation protection dosimetry, 143(2-4), 402-408.
[16] CRU, M. (1983). Report 36. International Commission on Radiation Units and Measurements, Bethesda, MD.
[17] Zaider, M., Rossi, B. H. H., & Zaider, M. (1996). Microdosimetry and its Applications. John Libbey..
[18] Pihet, P., Menzel, H. G., Schmidt, R., Beauduin, M., & Wambersie, A. (1990). Biological weighting function for RBE specification of neutron therapy beams. Intercomparison of 9 European centres. Radiation Protection Dosimetry, 31(1-4), 437-442.
[19] De Nardo, L., Moro, D., Colautti, P., Conte, V., Tornielli, G., & Cuttone, G. (2004). Microdosimetric investigation at the therapeutic proton beam facility of CATANA. Radiation protection dosimetry, 110(1-4), 681-686.
[20] Kase, Y., Kanai, T., Matsumoto, Y., Furusawa, Y., Okamoto, H., Asaba, T., ... & Shinoda, H. (2006). Microdosimetric measurements and estimation of human cell survival for heavy-ion beams. Radiation research, 166(4), 629-638.
[21] International Commission on Radiation Units and Measurements. (1986). The quality factor in radiation protection. ICRU Report 40.
[22] Tilikidis, A., Lind, B., Näfstadius, P., & Brahme, A. (1996). An estimation of the relative biological effectiveness of 50 MV bremsstrahlung beams by microdosimetric techniques. Physics in Medicine & Biology, 41(1), 55.
[23] Loncol, T., Cosgrove, V., Denis, J. M., Gueulette, J., Mazal, A., Menzel, H. G & Sabattier, R. (1994). Radiobiological effectiveness of radiation beams with broad LET spectra: microdosimetric analysis using biological weighting functions.Radiation Protection Dosimetry, 52(1-4), 347-352.
[24] Y. Hsu, F., J. Tung, C., & E. Watt, D. (2003). Microdosimetric spectra of the THOR neutron beam for boron neutron capture therapy. Radiation protection dosimetry, 104(2), 121-126.
[25] Coutrakon, G., Cortese, J., Ghebremedhin, A., Hubbard, J., Johanning, J., Koss, P., ... & Robertson, J. (1997). Microdosimetry spectra of the Loma Linda proton beam and relative biological effectiveness comparisons. Medical Physics,24(9), 1499-1506.
[26] Lillhök, J. E., Grindborg, J. E., Lindborg, L., Gudowska, I., Carlsson, G. A., Söderberg, J., ... & Medin, J. (2007). Nanodosimetry in a clinical neutron therapy beam using the variance-covariance method and Monte Carlo simulations.Physics in Medicine & Biology, 52(16), 4953.
[27] Salvat, F., Fernández-Varea, J. M., & Sempau, J. (2006, July). PENELOPE-2006: A code system for Monte Carlo simulation of electron and photon transport. In Workshop proceedings (Vol. 4, No. 7).
[28] Nikjoo, H., Uehara, S., Emfietzoglou, D., & Cucinotta, F. A. (2006). Track-structure codes in radiation research. Radiation Measurements, 41(9-10), 1052-1074.
[29] Incerti, S., Baldacchino, G., Bernal, M., Capra, R., Champion, C., Francis, Z., ... & Nieminen, P. (2010). The geant4-dna project. International Journal of Modeling, Simulation, and Scientific Computing, 1(02), 157-178.
[30] Sato, T., Kase, Y., Watanabe, R., Niita, K., & Sihver, L. (2009). Biological dose estimation for charged-particle therapy using an improved PHITS code coupled with a microdosimetric kinetic model. Radiation Research, 171(1), 107-117.
[31] Francis, Z., Incerti, S., Ivanchenko, V., Champion, C., Karamitros, M., Bernal, M. A., & El Bitar, Z. (2011). Monte Carlo simulation of energy-deposit clustering for ions of the same LET in liquid water. Physics in Medicine & Biology, 57(1), 209.
[32] Burigo, L., Pshenichnov, I., Mishustin, I., & Bleicher, M. (2014). Microdosimetry spectra and RBE of 1H, 4He, 7Li and 12C nuclei in water studied with Geant4. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 320, 89-99.
[33] Bernal, M. A., Bordage, M. C., Brown, J. M. C., Davídková, M., Delage, E., El Bitar, Z. & Karamitros, M. (2015). Track structure modeling in liquid water: A review of the Geant4-DNA very low energy extension of the Geant4 Monte Carlo simulation toolkit. Physica Medica: European Journal of Medical Physics,31(8), 861-874.
[34] Allision, J. (2006). Geant4 developments and applications IEEE Transactions on Nuclear Science 53 No. 1 (2006) 270-278.
[35] Cerullo, N., Bufalino, D., & Daquino, G. (2009). Progress in the use of gadolinium for NCT. Applied Radiation and Isotopes, 67(7-8), S157-S160.
[36] Panijpan, B. (1977). The buoyant density of DNA and the G+ C content. Journal of chemical education, 54(3), 172.
[37] Kellerer, A. M. (1971). Considerations on the random traversal of convex bodies and solutions for general cylinders. Radiation Research, 47(2), 359-376.
[38] Brun, R., & Rademakers, F. (1997). ROOT—an object oriented data analysis framework. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 389(1-2), 81-86.
[39] Kellerer, A. M., & Hahn, K. (1988). The quality factor for neutrons in radiation protection: Physical parameters. Radiation Protection Dosimetry, 23(1-4), 73-78.
[40] De Stasio, G., Rajesh, D., Ford, J. M., Daniels, M. J., Erhardt, R. J., Frazer, B. H., ... & Fowler, J. F. (2006). Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei. Clinical cancer research, 12(1), 206-213.
[41] Yasui, L. S., Andorf, C., Schneider, L., Kroc, T., Lennox, A., & Saroja, K. R. (2008). Gadolinium neutron capture in glioblastoma multiforme cells. International journal of radiation biology, 84(12), 1130-1139.